LC-MB12
CAS No. 2828438-38-4
LC-MB12 ( —— )
产品货号. M37588 CAS No. 2828438-38-4
LC-MB12 是一种具有口服活性靶向降解 FGFR2 的 PROTAC 化合物,DC50 为 11.8 nM。LC-MB12 包含 BGJ398 (FGFR2 抑制剂), PROTAC linker 和 CRBN。LC-MB12 抑制胃癌细胞 FGFR2 信号,具有抗肿瘤活性。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥2028 | 有现货 |
|
| 5MG | ¥2786 | 有现货 |
|
| 10MG | ¥4441 | 有现货 |
|
| 25MG | ¥8602 | 有现货 |
|
| 50MG | ¥13763 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称LC-MB12
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述LC-MB12 是一种具有口服活性靶向降解 FGFR2 的 PROTAC 化合物,DC50 为 11.8 nM。LC-MB12 包含 BGJ398 (FGFR2 抑制剂), PROTAC linker 和 CRBN。LC-MB12 抑制胃癌细胞 FGFR2 信号,具有抗肿瘤活性。
-
产品描述LC-MB12 is an orally active PROTAC compound targets FGFR2degradation with a DC50 of 11.8 nM. LC-MB12 contains BGJ398 (a FGFR2 inhibitor), PROTAC linker and CRBN.LC-MB12 inhibits FGFR2 signaling in gastric cancer cells and has anti-tumor activity.
-
体外实验Cell Viability Assay Cell Line:KATO III, SNU-16, NCI-H716 Concentration:0.5 nM, 1.5 nM, 4.3 nM, 13 nM, 41 nM, 123 nM, 370 nM, 1111 nM, 3333 nM, 10000 nM Incubation Time:72 h Result:Inhibited cell growth with IC50s value of 29.1 nM (KATO III); 3.7 nM (SNU-16); 3.2 nM (NCI-H716).Cell Cycle Analysis Cell Line:KATO III Concentration:29.1 nM Incubation Time:72 h Result:Induced G0/G1 cycle arrest.ImmunofluorescenceCell Line:KATO IIIConcentration:100 nM Incubation Time:3 h, 6 h Result:Promoted FGFR2 was relocated from the cell membrane to intracellular vesicles after treated for 3 or 6 h. Induced receptor internalization and re-localization to the perinuclear section after 6 h treatment.Western Blot Analysis Cell Line:KATO III, NCI-H1581 Concentration: 0.5 nM, 1.5 nM, 4.3 nM, 13 nM, 41 nM, 123 nM, 370 nM, 1111 nM, 3333 nM, 10000 nM Incubation Time:6 h Result:Degraded FGFR2 with a DC50 of 11.8 nM and D max of ~80% after 6 h of treatment.Showed time-dependent effect on degradation,with a detectable reduction in FGFR2 levels after 3 h of treatment and ~90% degradation after 12 h.Degraded of FGFR2 in KATO by 77%, and in NCI-H1581 by 43% after 100 nM treatment for 6 h.
-
体内实验Animal Model:SNU-16 xenografted in BALB/c-nu mice.Dosage:20 mg/kg/day Administration:oral administration (p.o.) 15 days Result:Achieved 63.1% tumor growth inhibition innocuously. Inhibited FGFR phosphorylation and total FGFR2 protein and decreased phosphorylation levels of downstream pPLCγ and ERK1/2.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体PROTACs | FGFR
-
研究领域——
-
适应症——
化学信息
-
CAS Number2828438-38-4
-
分子量899.78
-
分子式C43H44Cl2N10O8
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 130 mg/mL (144.48 mM; 超声助溶 (<60°C)
-
SMILESO=C(NC=1C(Cl)=C(OC)C=C(OC)C1Cl)N(C=2N=CN=C(C2)NC3=CC=C(C=C3)N4CCN(C(=O)C5CCN(C6=CC=C7C(=O)N(C(=O)C7=C6)C8C(=O)NC(=O)CC8)CC5)CC4)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Ma L, et al. Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric Cancer. J Med Chem. 2023 Jun 8;66(11):7438-7453.?
产品手册
关联产品
-
3,6-Disinapoylsucros...
3,6-二芥子酰蔗糖。
-
Chrysophanol 8-O-glu...
Chrysophanol 8-O-glucoside 和大黄酚具有轻微的细胞毒性和抗糖尿病特性,可以在胰岛素刺激的葡萄糖转运途径中发挥代谢作用。
-
Hydroxocobalamin ace...
醋酸羟钴胺是一种可注射的天然维生素 B12 形式,具有良好的副作用,可用作治疗维生素 B12 缺乏症(包括恶性贫血)的膳食补充剂。
021-51111890
购物车()
sales@molnova.cn

